Page 36 - Read Online
P. 36

Afyouni et al. Hepatoma Res 2023;9:28  https://dx.doi.org/10.20517/2394-5079.2023.29  Page 5 of 14
















































                Figure 3. Intrahepatic cholangiocarcinoma (ICC) in a 57-year-old female. Axial gadolinium-enhanced T1-weighted MR image in
                hepatoarterial phase (A) and portal venous phase (B) shows a hypointense large mass (arrow) with capsular retraction and also
                progressive central enhancement on portal venous phase. Axial T2-weighted MR image; (C) shows the tumor has heterogeneous high
                signal intensity. Axial Evoist-enhanced T1-weighted MR image (D) shows rim-enhancing centrally necrotic mass.  Axial diffusion-
                weighted MR image (E) demonstrates that the tumor restricts diffusion with the heterogeneous peripheral increased signal. ADC map
                (F) demonstrates a low ADC value in the rim area and a heterogenous higher ADC value in the center of the lesion.

               Jiang et al. provided the first nonsurgical-pathological prediction model (Fudan scoring system) for ICC,
               which required clinical data obtained before surgery through imaging and biochemical blood tests and
               could be used as a prediction model for unresectable ICC. However, the author mentioned that this model’s
               subjective assessment of tumor margins is a significant limitation that could lower prediction accuracy, so a
               more objective parameter is required. Ignorance of lymph node (LN) status is another limitation pointed
               out by the author, which has been strongly associated with prognosis and poor prediction accuracy .
                                                                                                  [45]

               According to prior research, factors related to postoperative survival in patients with ICC include
               microvascular invasion (MVI), tumor size, tumor grade, multiple tumors, and lymph node involvement .
                                                                                                      [46]
               MVI, an important predictor of ICC outcome, is characterized by the presence of a tumor in a portal vein,
                                                  [47]
               hepatic vein, or a large capsular vessel . To date, MVI can only be identified through postoperative
               pathology and is only helpful as a reference factor for adjuvant chemotherapy following ICC surgery.
               Consequently, it is essential to predict MVI before surgery. According to the study by Lee et al., the level of
   31   32   33   34   35   36   37   38   39   40   41